SEARCH

SEARCH BY CITATION

References

  • 1
    Asfar P, Balazs H, Radermacher P, et al. Catecholamines and vasopressin during critical illness. Crit Care Clin 2006; 22:131149.
  • 2
    Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345 (8):558595.
  • 3
    Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 2-clinical physiology. Crit Care 2004; 8:1523.
  • 4
    Scharte M, Meyer J, Van Aken H, et al. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29 (9):17561759.
  • 5
    Takakura K, Xianhong W, Takeuchi K, et al. Deactivation of norepinephrine by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anesthesiology 2003; 98 (4):928934.
  • 6
    Archer SL, Huang JMC, Hampl V, et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 91:75837587.
  • 7
    Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999; 100:226229.
  • 8
    Feldman EC, Nelson RW. Water metabolism and diabetes insipidus, In: FeldmanEC, NelsonRW, eds. Canine and Feline Endocrinology and Reproduction, 3rd ed. Philadelphia: WB Saunders Co; 2004, pp. 243.
  • 9
    Bourque CW, Oliet SHR, Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol 1994; 15:231274.
  • 10
    Swabb DF, Nijveldt F, Pool CW. Distribution of oxytocin and vasopressin in the rat suproptic and paraventricular nucleus. J Endocr 1975; 67:461462.
  • 11
    Rose DB, Post TW. Effects of hormones on renal function, In: RoseDB, PostTW, eds. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed. New York: McGraw-Hill Co; 2001, pp. 163238.
  • 12
    Leng G, Brown CH, Russel JA. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 1999; 57:625655.
  • 13
    Holmes CL, Patel BM, Russell JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120:9891002.
  • 14
    Czaczkes JW. Physiologic studies of antidiuretic hormone by its direct measurement in human plasma. J Clin Invest 1964; 43:16251640.
  • 15
    Kovacs L, Robertson GL. Syndrome of inappropriate antidiuresis. Endocrinol Metab Clin North Am 1992; 859875.
  • 16
    Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979; 236 (4):F321F332.
  • 17
    Guyton AC, Hall JE. Regulation of extracellular fluid osmolarity and sodium concentration, In: GuytonAC, HallJE, eds. Textbook of Medical Physiology, 10th ed. Philadelphia: WB Saunders Co; 2000, pp. 313328.
  • 18
    Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95 (5):11221125.
  • 19
    Leng G, Dyball RE, Russell JA. Neurophysiology of body fluid homeostasis. Comp Biochem Physiol A 1988; 90:781788.
  • 20
    Wood CE, Chen HG. Acidemia stimulates ACTH, vasopressin, and heart rate responses in fetal sheep. Am J Physiol 1989; 257:R344R349.
  • 21
    Sklar AH, Schrier RW. Central nervous system mediators of vasopressin release. Physiol Rev 1983; 63:12431280.
  • 22
    Ried IA. Role of nitric oxide in the regulation of rennin and vasopressin secretion. Front Neuroendocrinol 1994; 15:351383.
  • 23
    Breitschwerdt EB, Root CR. Inappropriate secretion of antidiuretic hormone in a dog. J Am Vet Med Assoc 1979; 175 (2):181186.
  • 24
    Angstwurm M. Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects. Crit Care Med 2005; 33 (11):27132714.
  • 25
    Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1-receptor physiology. Crit Care 2003; 7:427434.
  • 26
    Bracco D, Dubois MJ. Hemodynamic support in septic shock: is restoring a normal blood pressure the right target? Crit Care Med 2005; 33 (9):21132115.
  • 27
    Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 1998; 156:223229.
  • 28
    Szumita PM, Enfanto CM, Greenwood B, et al. Vasopressin for vasopressor-dependent septic shock. Am J Health-Syst Pharm 2005; 62:19311936.
  • 29
    Asfar P, Pierrot M, Veal N, et al. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 2003; 31 (1):215220.
  • 30
    Asfar P, Hauser B, Ivanyi Z, et al. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 2005; 33 (2):373380.
  • 31
    Malay MB, Ashton JL, Dahl K, et al. Heterogeneity of the vasoconstrictory effect of vasopressin in septic shock. Crit Care Med 2004; 32 (6):13271331.
  • 32
    Martikainen TJ, Tenhunen JJ, Uusaro A, et al. The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 2003; 97:17561763.
  • 33
    Knotzer H, Maier S, Dunser MW, et al. Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model. Intensive Care Med 2006; 32:170174.
  • 34
    Westphal M, Stubbe H, Sielenkamper AW, et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29:301308.
  • 35
    Westphal M, Stubbe H, Sielenkamper AW, et al. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 2003; 31 (5):15021508.
  • 36
    Sun Q, Dimopoulos G, Nguyen DN, et al. Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003; 168 (4):481486.
  • 37
    Yoo JH, Kim MS, Park HM. Hemodynamic characteristics of vasopressin in dogs with severe hemorrhagic shock. J Vet Med Sci 2006; 68 (9):967972.
  • 38
    Silverstein DC, Waddell LS, Drobatz KJ, et al. Vasopressin therapy in dogs with dopamine-resistant hypotension and vasodilatory shock. J Vet Emerg Crit Care 2007; 17 (4):399408.
  • 39
    Malay MB, Ashton RC, Landry DW, et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47 (4):699703.
  • 40
    Klinzing S, Simon M, Reinhart K, et al. High-dose vasopressin in not superior to norepinephrine in septic shock. Crit Care Med 2003; 31 (11):26462650.
  • 41
    O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:12091210.
  • 42
    Van Haren FMP, Rozendaal FW, Van Der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003; 124 (6):22562260.
  • 43
    Morelli A, Rocco M, Conti G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinectic septic shock. Intensive Care Med 2004; 30:597604.
  • 44
    Holmes CL, Walley KR, Chittock DR, et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001; 27:14161421.
  • 45
    Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25 (8):12791282.
  • 46
    Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusion in vasodilatory septic shock. Crit Care Med 2001; 29 (3):487493.
  • 47
    Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576582.
  • 48
    Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock. Circulation 2003; 107:23132319.
  • 49
    Leone M, Albanese J, Delmas A, et al. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004; 22 (4):314319.
  • 50
    Dunser MW, Fries DR, Schobersberger W, et al. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? Anesth Analg 2004; 99:201206.
  • 51
    Luckner G, Dunser MW, Jochberger S, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005; 33 (11):26592666.
  • 52
    Dunser MW, Fries DR, Schobersberger W, et al. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? Anesth Analg 2004; 99:201216.
  • 53
    Felip J, Rosenkranz B. Mechanisms of vasopressin-induced platelet aggregation. Thromb Res 1987; 45:715.
  • 54
    Schmid PG, Abbound FM, Wendling MG, et al. Regional vascular effects of vasopressin: plasma levels and circulatory responses. Am J Physiol 1974; 227 (5):9981004.
  • 55
    Garcia-Villalon AL, Garcia JL, Fernandez N, et al. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol 1996; 260 (2–3):265268.
  • 56
    Laszlo F, Karacsony G, Pavo I, et al. Aggressive role of vasopressin in development of different gastric lesion in rats. Eur J Pharmacol 1994; 258:1522.
  • 57
    Laszlo F, Whittle B. Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemia. Eur J Pharmacol 1994; 260:265268.
  • 58
    Lindner KH, Strohmenger HU, Ensinger H, et al. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992; 77:662668.
  • 59
    Lindner KH, Brinkmann A, Pfenninger EG, et al. Effect of vasopressin on hemodynamic variables, organ blood flow, and acid base status in pig model of cardiopulmonary resuscitation. Anesth Analg 1993; 77:427435.
  • 60
    Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995; 91:215221.
  • 61
    Wenzel V, Lindner KH, Prengel AW, et al. Endobronchial vasopressin improves survival during cardiopulmonary resuscitation in pigs. Anesthesiology 1997; 86:13751381.
  • 62
    Wenzel V, Lindner KH, Augenstein S, et al. Intraosseous vasopressin improves coronary perfusion pressure rapidly during cardiopulmonary resuscitation in pigs. Crit Care Med 1999; 27 (8):15651569.
  • 63
    Wenzel V, Lindner KH, Krismer AC, et al. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 1999; 99:13791384.
  • 64
    Little CM, Marietta MH, Peng K, et al. Vasopressin alone or with epinephrine may be superior to epinephrine in a clinically relevant porcine model of pulseless electrical activity cardiac arrest. Am J Emerg Med 2006; 24:810814.
  • 65
    Prengel AW, Lindner KH, Keller A. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke 1996; 27:12411248.
  • 66
    Prengel AW, Linstedt U, Zenz M, et al. Effects of combined administration of vasopressin, epinephrine, and norepinephrine during cardiopulmonary resuscitation in pigs. Crit Care Med 2005; 33 (11):25872591.
  • 67
    Wenzel V, Linder KH, Krismer AC, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J Am Coll Cardiol 2000; 35 (2):527533.
  • 68
    Popp E, Vogel P, Teschendorf P, et al. Vasopressors are essential during cardiopulmonary resuscitation in rats: is vasopressin superior to adrenaline? Resuscitation 2007; 72:137144.
  • 69
    Schmittinger CA, Astner S, Astner L, et al. Cardiopulmonary resuscitation with vasopressin in a dog. Vet Anaesth Analg 2005; 32:112114.
  • 70
    Lindner KH, Prengel AW, Brinkmann A, et al. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996; 124:10611064.
  • 71
    Morris DC, Dereczyk BE, Grzybowski M, et al. Vasopressin can increase perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997; 4:878883.
  • 72
    Lindner KH, Dirks B, Strohmenger HU. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997; 340:535537.
  • 73
    Li PF, Chen TT, Zhand JM, et al. Clinical study on administration of vasopressin during closed-chest cardiopulmonary resuscitation. Chin Crit Care Med 1999; 11:2831.
  • 74
    Stiell IG, Hebert PC, Wells GA, et al. Vasopressin versus epinephrine for in-hospital cardiac arrest: a randomized controlled trial. Lancet 2001; 358:101109.
  • 75
    Jochberger S, Wenzel V, Dunser MW. Arginine vasopressin as a rescue vasopressor agent in operating room. Curr Opin Anaesthesiol 2005; 18:396404.
  • 76
    Wenzel V, Krismer AC, Arntz H, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350 (2):105113.
  • 77
    Aung K, Htay T. Vasopressin for cardiac arrest. A systemic review and meta-analysis. Arch Intern Med 2005; 165:1724.
  • 78
    Callaway CW, Hostler D, Doshi AA, et al. Usefulness of vasopressin administered with epinephrine during out-of-hospital cardiac arrest. Cardiology 2006; 98:13161321.
  • 79
    Grmec S, Mally S. Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: an observation cohort study. Cri Care 2006; 10 (R13):17.
  • 80
    Stockman W, Keyser JD, Brabant S, et al. Colon ischaemia and necrosis as a complication of prolonged but successful CPR. Resuscitation 2006; 71:260262.
  • 81
    Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med 2002; 30 (8):18991901.
  • 82
    Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536555.
  • 83
    ECC Committee. Subcommittees and Task Force of the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2005; 112:IV1IV203.
  • 84
    Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:13681377.
  • 85
    Powers J, Jacobi J. Pharmacologic treatment related to severe sepsis. AACN Adv Crit Care 2006; 17 (4):423432.
  • 86
    Aufderheide TP, Pirrallo RG, Yannopoulos D, et al. Incomplete chest wall decompression: a clinical evaluation of CPR performance by EMS personnel and assessment of alternative manual chest compression-decompression techniques. Resuscitation 2005; 65:353363.
  • 87
    Powell LL. Systemic inflammatory response in the cat: Current management recommendations. In: ACVIM Forum Proceedings; 2004: Minneapolis, MN. pp. 745–747.
  • 88
    Mathews KA. Indications and guidelines for “fluid” management in various situations. In: Proceedings of the Western Veterinary Conference; 2004: Las Vegas, NV. pp. 654–656.
  • 89
    Winso O, Biber B, Martner J. Does dopamine suppress stress-induced intestinal and renal vasoconstriction? Acta Anaesthesiol Scand 1985; 29 (5):508514.
  • 90
    Cadario BJ, Leathem AM. Drug Information Reference, 4th ed. Vancouver, BC: Drug and Poison Information Center; 1996, pp. 13011303.
  • 91
    Plunkett SJ, McMicheal M. Cardiopulmonary resuscitation in small animal medicine: an update. J Vet Intern Med 2008; 22:925.
  • 92
    Salam AM. The therapeutic potential of vasopressin in cardiopulmonary resuscitation. Expert Opin Pharmacother 2005; 6:517520.